Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Hepatocarcinogenesis is a stepwise process and multiple genes alteration are involved such as activation of oncogenes, inactivation of tumor suppressor genes, activation of growth factor and their cognitive receptors, reactivation of developmental pathways and activation of cell cycle regulator. In general, MAPK and the PIK3CA signalling pathways have a key role in cell proliferation and survival and their oncogenic activation deeply contributes to pathogenesis of different solid tumors. B-Raf mutation has been reported in 61% of melanoma, 53% of papillary thyroid cancer and 11.5% of colorectal cancer patients. In case of hepatoma, 23% of B-RafV600E mutation has been reported. Furthermore, PI3K pathway activation was found about 40% of HCC cases. Therefore, in this study, we evaluated the role of B-RafV600E and PI3K pathway signaling in hepatocarcinogenesis. Overexpression of B-RafV600E in primary human hepatocytes caused cell growth arrest and increased senescence-associated beta-galactosidase (SA-β-gal) staining. Furthermore, we found that shPTEN induced cellular senescence. We further investigated that shPTEN and B-RafV600E co-infection effect in hepatocarcinogenesis and found that overcome of senescence was observed. At the mechanism level, B-RafV600E infection decreased FoxM1 expression. However, co-infection increased FoxM1 expression. Furthermore, B-RafV600E and FoxM1 co-infected hepatocytes also showed overcome of B-RafV600E induced senescence.